Kindred Biosciences (KIN) Stock Price, Quote, News and Overview

What is the stock price of Kindred Biosciences today?

The current stock price of KIN is 9.25 null. The price increased by 0.11% in the last trading session.

What is the ticker symbol for Kindred Biosciences stock?

The exchange symbol of Kindred Biosciences is KIN and it is listed on the Nasdaq exchange.

On which exchange is KIN stock listed?

KIN stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for Kindred Biosciences stock?

5 analysts have analysed KIN and the average price target is 9.69 null. This implies a price increase of 4.76% is expected in the next year compared to the current price of 9.25. Check the Kindred Biosciences stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Kindred Biosciences worth?

Kindred Biosciences (KIN) has a market capitalization of 420.52M null. This makes KIN a Small Cap stock.

How many employees does Kindred Biosciences have?

Kindred Biosciences (KIN) currently has 63 employees.

What are the support and resistance levels for Kindred Biosciences (KIN) stock?

Kindred Biosciences (KIN) has a support level at 9.24 and a resistance level at 9.26. Check the full technical report for a detailed analysis of KIN support and resistance levels.

Is Kindred Biosciences (KIN) expected to grow?

The Revenue of Kindred Biosciences (KIN) is expected to decline by -49.68% in the next year. Check the estimates tab for more information on the KIN EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Kindred Biosciences (KIN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of KIN, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of KIN, evaluating the profitability, health, valuation and growth aspects
• Kindred Biosciences (KIN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Kindred Biosciences (KIN) Sales and EPS estimates to see what analysts future expectations are.
• Kindred Biosciences (KIN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Kindred Biosciences (KIN) Insider and Institutional Ownership to learn about the owners and their transactions.
• Kindred Biosciences (KIN) Stock Chart to make your own analysis
• Kindred Biosciences (KIN) Latest news and press-releases to stay up to date.

Does Kindred Biosciences (KIN) stock pay dividends?

KIN does not pay a dividend.

When does Kindred Biosciences (KIN) report earnings?

Kindred Biosciences (KIN) will report earnings on 2022-03-15, after the market close.

What is the Price/Earnings (PE) ratio of Kindred Biosciences (KIN)?

Kindred Biosciences (KIN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.03).

ChartMill assigns a fundamental rating of 3 / 10 to KIN. While KIN seems to be doing ok healthwise, there are quite some concerns on its profitability.

Over the last trailing twelve months KIN reported a non-GAAP Earnings per Share(EPS) of -1.03. The EPS decreased by -53.73% compared to the year before.

ChartMill assigns a Buy % Consensus number of 60% to KIN. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of -51.22% and a revenue growth -49.68% for KIN